CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High-Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value
CBD Life Sciences Inc. (CBDL) announces strategic entry into the CBD equine market, targeting an underserved niche within the $125 million CBD pet care industry. The market is projected to grow at a 40.3% CAGR through 2028. CBDL's equine-specific products offer natural wellness and therapeutic benefits, developed by veterinary experts to address horses' specific needs. The company aims to capitalize on the relatively untapped equine segment, differentiating itself from the crowded household pet sector. CBDL reports achieving 1405.46% growth since early 2024 across various product categories.
CBD Life Sciences Inc. (CBDL) annuncia un'entrata strategica nel mercato equino del CBD, mirando a una nicchia poco servita all'interno dell'industria della cura degli animali domestici CBD da 125 milioni di dollari. Si prevede che il mercato crescerà a un CAGR del 40,3% fino al 2028. I prodotti specifici per equini di CBDL offrono benefici naturali per il benessere e terapeutici, sviluppati da esperti veterinari per soddisfare le esigenze specifiche dei cavalli. L'azienda mira a capitalizzare sul segmento equino relativamente inesplorato, distinguendosi dal settore affollato degli animali domestici. CBDL riporta di aver raggiunto una crescita del 1405,46% dalla metà del 2024 attraverso varie categorie di prodotti.
CBD Life Sciences Inc. (CBDL) anuncia su entrada estratégica en el mercado equino de CBD, enfocándose en un nicho desatendido dentro de la industria de cuidado de mascotas de CBD de 125 millones de dólares. Se proyecta que el mercado crecerá a un CAGR del 40,3% hasta 2028. Los productos específicos para equinos de CBDL ofrecen beneficios naturales para el bienestar y terapéuticos, desarrollados por expertos veterinarios para satisfacer las necesidades específicas de los caballos. La empresa tiene como objetivo capitalizar el segmento equino relativamente no explorado, diferenciándose del sector de mascotas domésticas tan concurrido. CBDL informa que ha logrado un crecimiento del 1405,46% desde principios de 2024 en varias categorías de productos.
CBD 생명 과학 주식회사(CBDL)가 CBD 말 시장에 전략적으로 진입한다고 발표하며, 1억 2500만 달러 규모의 CBD 반려동물 관리 산업 내에서 소홀히 다뤄졌던 틈새 시장을 겨냥하고 있습니다. 이 시장은 2028년까지 40.3%의 연평균 성장률(CAGR)로 성장할 것으로 예상됩니다. CBDL의 말 전용 제품은 자연적인 웰빙 및 치료 혜택을 제공하며, 말의 특정 요구 사항을 해결하기 위해 수의학 전문가에 의해 개발되었습니다. 이 회사는 상대적으로 미개척된 말 부문에서 수익을 창출하고, 혼잡한 가정용 애완동물 시장에서 차별화하는 것을 목표로 합니다. CBDL은 다양한 제품 카테고리에서 2024년 초 이후로 1405.46% 성장을 달성했다고 보고했습니다.
CBD Life Sciences Inc. (CBDL) annonce une entrée stratégique sur le marché équin du CBD, ciblant une niche peu desservie au sein de l'industrie des soins pour animaux de compagnie CBD, qui s'élève à 125 millions de dollars. Le marché devrait connaître une croissance annuelle de 40,3% jusqu'en 2028. Les produits spécifiques au bien-être équin de CBDL offrent des bienfaits naturels et thérapeutiques, développés par des experts vétérinaires pour répondre aux besoins spécifiques des chevaux. L'entreprise vise à capitaliser sur le segment équin relativement peu exploité, en se différenciant du secteur surchargé des animaux de compagnie. CBDL rapporte avoir atteint une croissance de 1405,46% depuis début 2024 dans diverses catégories de produits.
CBD Life Sciences Inc. (CBDL) kündigt einen strategischen Einstieg in den CBD-Pferdemarkt an und zielt auf eine unzureichend bediente Nische innerhalb der 125 Millionen Dollar schweren CBD-Tierpflegeindustrie ab. Es wird erwartet, dass der Markt bis 2028 mit einer CAGR von 40,3% wächst. Die für Pferde spezifischen Produkte von CBDL bieten natürliche Wellness- und therapeutische Vorteile, die von Tierärzten entwickelt wurden, um die speziellen Bedürfnisse der Pferde zu adressieren. Das Unternehmen möchte das relativ unerschlossene Pferdesegment nutzen und sich vom überfüllten Haushalts-Tiersektor abheben. CBDL berichtet von einer Wachstumsrate von 1405,46% seit Anfang 2024 in verschiedenen Produktkategorien.
- Market entry into underserved CBD equine niche with less competition
- Strong industry growth projections with 40.3% CAGR through 2028
- Company reported 1405.46% growth since early 2024
- None.
The global CBD pet care market, which includes products for animals like dogs, cats, and horses, was valued at approximately
SCOTTSDALE, AZ / ACCESSWIRE / October 29, 2024 / CBD Life Sciences Inc. (CBDL), an innovative leader in the CBD industry, is positioning itself to capitalize on the rapidly expanding CBD pet care market with a bold entry into equine products. With the market expected to soar at a
CBDL's equine-specific products offer a powerful blend of natural wellness and therapeutic benefits, answering the demand from pet owners who increasingly seek alternative health solutions for their animals. Unlike the crowded household pet sector, the equine segment remains a relatively untapped market in the CBD space, allowing CBDL to leverage its proprietary formulations and quality-driven product development to build a strong market foothold.
"As a publicly traded company, CBD Life Sciences Inc. has the distinct advantage of bringing transparency and robust standards to a burgeoning industry," stated Lisa Nelson, CEO of CBDL. "Our innovative equine line is positioned to capture meaningful market share in an area of rapid growth, giving shareholders and investors a unique investment in a high-demand, low-competition sector."
This equine-focused strategy is supported by growing consumer demand for safe, effective, and scientifically backed products that improve animal wellness. CBDL's equine formulations, meticulously crafted to deliver both physical and psychological support, have been developed by veterinary experts to address the specific needs of horses, with benefits that include reducing inflammation, improving recovery times, and enhancing overall well-being.
The decision to target equine products also aligns with broader market trends toward natural and integrative health solutions for pets, as highlighted in the Grand View Research report on CBD Pet Market Size, Share & Trends Analysis. According to the report, pet owners are increasingly turning to CBD-based products to promote the wellness of their animals, which not only validates CBDL's direction but also suggests high growth potential for the brand's expanding pet care line.
Positioned to Benefit Shareholders with High Growth and Market Visibility
With CBDL's entry into the equine market, the company is poised for substantial revenue growth, making it an attractive investment opportunity for shareholders seeking exposure to both the booming CBD sector and the rising pet care industry. CBDL has demonstrated a solid track record of revenue increases and product success, achieving a notable
Grand View Research Link: https://www.grandviewresearch.com/industry-analysis/cannabidiol-pet-market
About CBD Life Sciences, Inc.
CBD Life Sciences, Inc. (OTC PINK:CBDL) is a leading innovator in the CBD and wellness industry, committed to creating high-quality, scientifically backed products that promote health and well-being. From pain relief to overall wellness, CBD Life Sciences strives to deliver top-tier solutions that meet the needs of today's consumers.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
Related Images
|
SOURCE: CBD Life Sciences Inc.
View the original press release on accesswire.com
FAQ
What is the projected CAGR for the CBD pet care market through 2028?
What was CBDL's growth rate in 2024?
What is the current value of the global CBD pet care market?
What specific market segment is CBDL targeting with its new strategy?
